Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet. 2021;397(10284):1577–90.
2. Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33.
3. US FDA. FDA grants accelerated approval for Alzheimer’s disease treatment [media release]; 6 Jan 2023. https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment.
4. Dhillon S. Aducanumab: first approval. Drugs. 2021;81(12):1437–43.
5. Eisai Inc. LEQEMBI™ (lecanemab-irmb) injection, for intravenous use: US prescribing information; 2023. https://www.fda.gov/. Accessed 10 Jan 2023.
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献